Izotropic Completes IzoView Development and Assembly, Prepares for Final Testing
Vancouver, British Columbia–(Newsfile Corp. – December 1, 2022) – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic” or the “Company“), a medical device company commercializing IzoView, a dedicated…
